申请人:Fujian Institute Of Research On The Structure Of
Matter, Chinese Academy Of Sciences
公开号:EP2835372A1
公开(公告)日:2015-02-11
This invention provides thieno[2,3-d]pyrimidine derivatives containing isoxazole heterocycle represented by formula (I), or pharmaceutically acceptable salts thereof
Wherein: R1 and R2 may be the same or different and is independently to each other selected from H, C1-6 alkyl, C1-6 alkoxy, halo-C1-6 alkyl or halo-C1-6 alkoxy, aryl group optionally substituted by R7 or heteroaryl group optionally substituted by R8; or R1 and R2 together with the carbon atoms to which they are attached, may form a 4- to 6-membered carbocyclic ring or heterocyclic ring; said carbocyclic ring or heterocyclic ring is optionally substituted by H, C1-6 alkyl, halogen, nitro, or amino; said heterocyclic ring contains at least one heteroatom selected from N, O or S; Z is -NR6-, C(R6)2, -S- or -O-, in which R5 is H or C1-6 alkyl, and R6 is the same or different, selected from H, C1-6 alkyl or hydroxyl substituted C1-6 alkyl; R3 is selected from H, halogen, C1-6 alkyl, C1-6 alkoxy, halo-C1-6 alkyl or halo-C1-6 alkoxy; n is an integer of 0-5; R4 is selected from H, C1-6 alkyl, C1-6 alkoxy or halo-C1-6 alkyl, aryl group optionally substituted by R9, or heteroarylgroup optionally substituted by R10; R7, R8, R9 or R10 independently to each other, is selected from H, hydroxy, mercapto, cyano, amino, nitro, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, carboxy, halo-C1-6 alkyl or halo-C1-6 alkoxy. This invention also provides the preparation method and medicinal uses of the compounds of formula (I) and pharmaceutically acceptable salts thereof. and this class of compounds can be used as medicants or lead compounds for the treatment of diseases such as tumors, cancers.
本发明提供了含有式(I)代表的
异噁唑杂环的
噻吩并[2,3-d]
嘧啶衍
生物或其药学上可接受的盐类
其中R1 和 R2 可以相同或不同,且彼此独立地选自 H、C1-6 烷基、C1-6 烷氧基、卤代-C1-6 烷基或卤代-C1-6 烷氧基、任选被 R7 取代的芳基或任选被 R8 取代的杂芳基;或 R1 和 R2 与它们所连接的碳原子一起可形成 4 至 6 元碳环或杂环;所述碳环或杂环可选择被 H、C1-6 烷基、卤素、硝基或
氨基取代;所述杂环包含至少一个选自 N、O 或 S 的杂原子;Z 是-NR6-、C(R6)2、-S- 或-O-,其中 R5 是 H 或 C1-6 烷基,R6 相同或不同,选自 H、C1-6 烷基或羟基取代的 C1-6 烷基;R3 选自 H、卤素、C1-6 烷基、C1-6 烷氧基、卤代-C1-6 烷基或卤代-C1-6 烷氧基;n 是 0-5 的整数;R4选自H、C1-6烷基、C1-6烷氧基或卤代-C1-6烷基、任选被R9取代的芳基或任选被R10取代的杂芳基;R7、R8、R9或R10相互独立地选自H、羟基、巯基、
氰基、
氨基、硝基、卤素、C1-6烷基、C1-6烷氧基、C1-6烷
硫基、羧基、卤代-C1-6烷基或卤代-C1-6烷氧基。本发明还提供了式(I)化合物及其药学上可接受的盐的制备方法和药用用途。这类化合物可用作治疗肿瘤、癌症等疾病的药物或先导化合物。